The global valganciclovir market continues to gain momentum as healthcare providers increasingly focus on preventing and treating cytomegalovirus (CMV) infections among immunocompromised individuals. Valganciclovir is an orally administered antiviral medication that rapidly converts into ganciclovir after absorption, making it highly effective in controlling CMV infections while offering...